[at noodls] – – New Treatment for Adults with Irritable Bowel Syndrome with Constipation or Chronic Idiopathic Constipation Now in Pharmacies Across the U.S.- Dateline: CAMBRIDGE, Mass. & NEW YORK CAMBRIDGE, Mass. & … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]
[at noodls] – NEW YORK & BARCELONA, Spain–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM:MC) announced today that Tudorzaâ„¢ Pressairâ„¢ (aclidinium bromide inhalation powder) 400mcg is now … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]
[at noodls] – New treatment for COPD now available in U.S. pharmacies In Europe, aclidinium is already available in Germany, the UK and Denmark Aclidinium + formoterol phase III topline results available in first half … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here […]
[at noodls] – NEW YORK–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE: FRX) and Forest Laboratories Holdings, Ltd. (collectively,Forest) announced today that they have entered into settlement agreements … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Cariprazine was discovered by Gedeon Richter Plc. and is licensed to Forest Laboratories Inc., in the U.S. and Canada. The application for the treatment of schizophrenia includes results from three positive … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NEW YORK–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE: FRX) and Forest Laboratories Holdings, Ltd. (collectively, Forest) announced today that they have entered into a settlement agreement … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NEW YORK & SAO PAULO–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical company, and moksha8, a leader in the commercialization of CNS medicines in Latin America, … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Company Provides Fiscal Year 2013 Revised GAAP EPS Guidance in the Range of $0.15-$0.30 Per Share Non-GAAP EPS will be in the Range of $0.45-$0.60 Per Share NEW YORK–(BUSINESS WIRE)–Forest Laboratories, … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboard […]
